Related Articles
Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells
Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (Review)
Bisphosphonates regulate cell proliferation, apoptosis and pro-osteoclastic expression in MG‑63 human osteosarcoma cells
Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer
The RANKL/RANK system as a therapeutic target for bone invasion by oral squamous cell carcinoma (Review)